Analysis of the cerebrospinal fluid (CSF) of patients with relapsing-remitting MS showed higher levels of FGF2 expression than healthy controls and revealed that an increased concentration of FGF2 positively correlates with lesion load of disease activity [14]. The gene discussed is FGF2; the disease is relapsing-remitting multiple sclerosis.